HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FDA approves pralatrexate for treatment of rare lymphoma.

AuthorsCheryl A Thompson
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (Am J Health Syst Pharm) Vol. 66 Issue 21 Pg. 1890 (Nov 01 2009) ISSN: 1535-2900 [Electronic] England
PMID19850775 (Publication Type: News)
Chemical References
  • 10-propargyl-10-deazaaminopterin
  • Antineoplastic Agents
  • Folic Acid Antagonists
  • Aminopterin
Topics
  • Aminopterin (analogs & derivatives, therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Drug Approval
  • Folic Acid Antagonists (therapeutic use)
  • Humans
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: